David Grainger Net Worth & Insider Trades

David Grainger - Chief Innovation Officer, Centessa Pharmaceuticals Plc

As of October 4, 2022

What is David Grainger's Net Worth?

The current estimated net worth of Centessa Pharmaceuticals Plc's Chief Innovation Officer, David Grainger, is estimated to be about $114.79K . David Grainger owns about 936,075 units of Centessa Pharmaceuticals Plc common stock. In the last year at Centessa Pharmaceuticals Plc, David Grainger has sold an estimated value of $20.74K worth.

What is David Grainger's Past Insider Trading?

David Grainger's largest purchase order was 27,500 units , worth over $248.75K on February 1, 2022. David Grainger's largest sale order was 5,181 units , worth over $20.74K on October 4, 2022. In total, David Grainger has made about 5 transactions over a year of their time at Centessa Pharmaceuticals Plc. David Grainger usually trades in February, with the busiest year in 2022.

DAVID GRAINGER

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is David Grainger's' Mailing Address?

  • Mailing address is C/o Centessa Pharmaceuticals Plc 3rd Fl., 1 Ashley Rd, Altrincham Cheshire X0 WA14 2DT United Kingdom

What are Centessa Pharmaceuticals Plc's Past Insider Trades?

Centessa Pharmaceuticals Plc's most recent insider trade came on December 5, 2022 by Antoine Yver who sold 9,400 units worth $36.74K . In the last year, insiders at Centessa Pharmaceuticals Plc have sold an estimated value of $1.03M and bought an estimated value of $75.13M worth of shares. Insider trading is most common in July, with the busiest year in 2022. The most active traders at the company are Antoine Yver, EVP & Chairman Development,  David Grainger, Chief Innovation Officer,  and Francesco Rubertis de, Director .

Centessa Pharmaceuticals plc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1